Status:
COMPLETED
Current Role of Pentafecta Outcomes in Open and Laparoscopic Partial Nephrectomy for Localized Renal Tumors
Lead Sponsor:
South Valley University
Conditions:
Pentafecta
Laparoscopic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aimed to identify predictive factors associated with the achievement of pentafecta outcomes following partial nephrectomy.
Detailed Description
Partial nephrectomy (PN) is widely considered the preferred treatment for clinical T1 (cT1) renal masses, primarily because it preserves kidney function more effectively than radical nephrectomy. The...
Eligibility Criteria
Inclusion
- Age ≥ 18 years.
- Both sexes.
- Patients who diagnosed with clinical T1 or T2a N0M0 renal tumors who were suitable candidates for partial nephrectomy
Exclusion
- Severe and irreversible coagulopathy.
- Anatomically unfavorable tumor location.
- Extensive encasement of the renal pedicle.
- Diffuse invasion of the renal vein or central collecting system.
- Adjacent organ invasion consistent with stage cT4 disease.
- Regional lymphadenopathy (stage cTxN1), or anticipated retention of less than 20% of total nephron mass.
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2024
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06969131
Start Date
May 1 2022
End Date
May 1 2024
Last Update
May 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
South Valley university
South Valley, Qena Governorate, Egypt, 83523